BALL KRISTINE M — SEC insider filings
SEC reporting owner CIK 1266163. 8 insider filings on record with FilingPulse; latest filed 2026-11-13.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2021-06-11 to 2026-11-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 6 legs across 1 filing — 18,000 shares, $1,888,749 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 8.
- Largest priced transaction: sale of 10,765 shares @ $105.31 ($1,133,706) in Oruka Therapeutics, Inc., filed 2026-11-13.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | Director | 3 | — | 6 legs · 18,000 sh · $1,888,749 | 4 |
| Atreca, Inc. (BCEL) | Director | 3 | — | — | 3 |
| Enliven Therapeutics, Inc. (ELVN) | Director | 2 | — | — | 1 |
Insider filings — BALL KRISTINE M
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-13 | 4 | Oruka Therapeutics, Inc. (ORKA) | Option exercise (M): 18,000 @ $6.84 · Sale (S): 1,196 @ $102.10 · Sale (S): 1,300 @ $103.09 · Sale (S): 2,039 @ $104.16 · Sale (S): 10,765 @ $105.31 · Sale (S): 2,500 @ $106.05 · +2 more | EDGAR |
| 2026-10-16 | 3 | Enliven Therapeutics, Inc. (ELVN) | Holdings only — no transactions reported | EDGAR |
| 2026-10-16 | 4 | Enliven Therapeutics, Inc. (ELVN) | Grant/award (A): 23,394 (derivative) @ $0 | EDGAR |
| 2026-06-03 | 4 | Oruka Therapeutics, Inc. (ORKA) | Grant/award (A): 9,136 (derivative) @ $0 | EDGAR |
| 2025-06-03 | 4 | Oruka Therapeutics, Inc. (ORKA) | Grant/award (A): 17,500 (derivative) @ $0 | EDGAR |
| 2023-06-15 | 4 | Atreca, Inc. (BCEL) | Grant/award (A): 12,000 (derivative) @ $0 | EDGAR |
| 2022-06-10 | 4 | Atreca, Inc. (BCEL) | Grant/award (A): 12,000 (derivative) @ $0 | EDGAR |
| 2021-06-11 | 4 | Atreca, Inc. (BCEL) | Grant/award (A): 12,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-29 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1266163 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs